Clinical Study

Metabolic and Genetic Screening of Electromagnetic Hypersensitive Subjects as a Feasible Tool for Diagnostics and Intervention

Figure 7

Selected representative parameters describing fatty acid (FA) patterns of erythrocyte membrane phospholipids, in the groups of patients self-reporting electromagnetic hypersensitivity (EHS, ), of patients affected by multiple chemical sensitivity without EHS symptoms (MCS, ), and of control healthy subjects (CTR, ). (a) % saturated and monounsaturated acid (SFA) on total FA content of phospholipids, (b) % polyunsaturated fatty acids (PUFA) on total FA content of phospholipids, and (c) ratio omega-6/omega3 PUFA. Values are represented as mean (□), standard error of the mean (upper and lower limits of the box), and 1.96× standard error (upper and lower whiskers). Intergroup significant differences (P) are reported under each panel. RBC: red blood cells.
924184.fig.007a
(a)
924184.fig.007b
(b)
924184.fig.007c
(c)